Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Statins in patients with type 2 diabetes

People with type 2 diabetes mellitus and coronary artery disease or any other risk for cardiovascular disease should be taking statins, state new guidelines from the American College of Physicians.

News image

fiogf49gjkf04

New guidelines state that people with type 2 diabetes mellitus and coronary artery disease, or diabetes and any other risk for cardiovascular disease should be taking statins.

New guidelines from the American College of Physicians (ACP) are published in the latest issue of the Annals of Internal Medicine.

This is the second ACP guideline on aggressive management of risk factors for cardiovascular disease in people with type 2 diabetes.

In April 2003, ACP called for tight control of blood pressure for people with diabetes.

An estimated 80% of people with type 2 diabetes will develop or die of complications of heart and vessel disease. About 65% of deaths among people with diabetes are due to heart disease and stroke, according to the American Diabetes Association.

"We want both physicians and patients to know that when treating diabetes, controlling cardiovascular risk factors, particularly cholesterol levels and high blood pressure, is as important as controlling blood sugar," said Dr Vincenza Snow of the American College of Physicians.

"In addition to controlling blood sugar levels, people with diabetes may be surprised to know that they must also be vigilant about controlling their blood pressure and cholesterol levels."

An estimated 18.2 million Americans have type 2 diabetes.
Annals of Internal Medicine

The numbers of people with type 2 diabetes is growing rapidly in the United States.

An estimated 18.2 million Americans, or about 6% of the population, have type 2 diabetes, and an additional 1.3 million people aged 20 or older are diagnosed with the disease each year, according to the American Diabetes Association.

The new ACP guidelines are targeted at both patients and primary care physicians.

For patients, ACP is issuing a video news release to alert people with type 2 diabetes and their families about the importance of controlling cholesterol.

For ACP physician members, evidence-based guidelines on all aspects of diabetes treatment are important.

ACP lists these guidelines to control cholesterol in people with diabetes:

  1. All adults with type 2 diabetes and known CAD should be taking statins, regardless of their cholesterol levels.
  2. All adults with type 2 diabetes and another risk factor for coronary artery disease, such as high blood pressure, high cholesterol, smoking, physical inactivity or obesity, should be taking statins or the non-statin drug gemfibrozil, regardless of cholesterol levels. This group includes premenopausal women with diabetes and another risk factor.
  3. Once started on cholesterol-lowering therapy, patients with type 2 diabetes should remain on at least moderate doses of a statin. Physicians should not delay starting statin treatment until cholesterol reaches a certain level and should not "treat to a target" level of cholesterol.
  4. Routine monitoring of liver function or muscle enzymes is probably not needed for those patients with type 2 diabetes who are taking statins, except if they also have a liver abnormality or muscle pain or are taking drugs that interact with statins.

The ACP guidelines call special attention to premenopausal women with diabetes.

"Women with diabetes who have not reached menopause may think their female hormones protect them from CAD," said Dr Snow.

"But statistics show that premenopausal women with type 2 diabetes and at least one other cardiovascular risk factor are as likely as men to develop CAD.

"So ACP says that women with diabetes and other risk factors for CAD should take a statin."

Diabetes is itself a major risk factor for heart disease. Other risk factors are high blood pressure, high blood cholesterol, physical inactivity, obesity and overweight, smoking, and older age.

The guidelines are based on a systematic review of evidence about cholesterol-lowering drug therapy in people with diabetes who have coronary disease already or who have risk factors for coronary disease.

In these studies, the authors looked at the benefits of tight lipid control in primary prevention and in secondary prevention.

The ACP authors concluded that statins are extremely safe, except for patients who have liver problems or are taking drugs that interact with statins.

Ann Intern Med 2004; 140(8):
20 April 2004

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us